Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke

BACKGROUND AND PURPOSE: Intravenous (IV) tissue plasminogen activator (tPA) is the only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke. Post tPA patients are typically monitored in an intensive care unit (ICU) for at least 24 hours. However, rigorous evidence to supp...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Faigle, Roland, Sharrief, Anjail, Marsh, Elisabeth B., Llinas, Rafael H., Urrutia, Victor C.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2014
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3922971/
https://ncbi.nlm.nih.gov/pubmed/24533130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0088652
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki